Does stopping a statin increase the short-term risk of a cardiovascular event?
Metadata[+] Show full item record
When hydroxymethyl glutaryl coenzyme A (HMG CoA) inhibitors (statins) are stopped by asymptomatic patients, there appears to be no increased risk of cardiovascular events (strength of recommendation [SOR]: B). However, for patients who have recently experienced a cardiovascular event, discontinuation of statins increases the risk of further events and death (SOR: B).
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.